Acute Asthma Exacerbation Protocol
Immediately administer oxygen to maintain SpO₂ >90% (>95% in pregnant patients or those with heart disease), high-dose albuterol, and systemic corticosteroids within the first 15-30 minutes of presentation. 1, 2
Initial Assessment (First 15 Minutes)
Severity Classification:
- Mild: Dyspnea only with activity, PEF ≥70% predicted, speaks in sentences 1
- Moderate: Dyspnea interfering with usual activity, PEF 40-69% predicted, speaks in phrases 1
- Severe: Dyspnea at rest, PEF <40% predicted, speaks in words, respiratory rate >25/min, heart rate >110/min 1
- Life-threatening: PEF <33% predicted, silent chest, cyanosis, altered mental status, PaCO₂ ≥42 mmHg, inability to speak 3, 1
Immediate Treatment Protocol
First-Line Therapies (Start Simultaneously)
1. Oxygen Therapy:
- Administer via nasal cannula or mask to maintain SpO₂ >90% (>95% in pregnancy/heart disease) 1, 2
- Monitor continuously until clear response to bronchodilators 1, 2
2. Short-Acting Beta-Agonist (Albuterol):
- Nebulizer: 2.5-5 mg every 20 minutes for 3 doses (first hour), then 2.5-10 mg every 1-4 hours as needed 3, 1, 2
- MDI with spacer: 4-8 puffs every 20 minutes for 3 doses (first hour), then as needed 1, 2
- For severe exacerbations (PEF <40%): Consider continuous nebulization 2
3. Systemic Corticosteroids (Administer Early):
- Adults: Prednisone 40-60 mg PO in single or divided doses 3, 1, 2
- Children: 1-2 mg/kg/day PO (maximum 60 mg/day) 1, 2
- Alternative: IV hydrocortisone 200 mg if unable to take oral 1
- Critical point: Clinical benefits may not occur for 6-12 hours, so early administration is essential 4, 5
Add-On Therapy for Moderate-to-Severe Exacerbations
4. Ipratropium Bromide:
- Add to albuterol for all moderate-to-severe exacerbations 3, 1, 2
- Adults: 0.5 mg via nebulizer or 8 puffs via MDI every 20 minutes for 3 doses, then as needed 3, 1, 2
- Children: 0.25-0.5 mg via nebulizer or 4-8 puffs via MDI every 20 minutes for 3 doses 3
- Evidence: Reduces hospitalizations, particularly in severe airflow obstruction 3, 6
Reassessment Protocol
After Initial Treatment (15-30 minutes):
- Measure PEF or FEV₁ before and after treatments 1, 2
- Assess symptoms, vital signs, oxygen saturation 1, 2
- Critical: Response to treatment is a better predictor of hospitalization need than initial severity 3, 1, 2
Repeat Assessment (60-90 minutes):
- All patients should be reassessed after 3 doses of bronchodilator (60-90 minutes) 3
- Include subjective response, physical findings, and objective measurements 3
Escalation for Severe/Refractory Cases
If inadequate response after initial treatment:
5. Intravenous Magnesium Sulfate:
- Indication: Life-threatening exacerbations or severe exacerbations remaining after 1 hour of intensive treatment 3, 1, 2
- Dose: 2 g IV over 20 minutes 1, 2
- Most effective when administered early 2
6. Monitor for Impending Respiratory Failure:
- Warning signs: Inability to speak, altered mental status, intercostal retractions, worsening fatigue, PaCO₂ ≥42 mmHg 3, 2
- Do not delay intubation once deemed necessary 3
Common Pitfalls to Avoid
- Underestimation of severity: Failure to make objective measurements (PEF/FEV₁) leads to underestimation by patients, relatives, and physicians 1
- Never administer sedatives of any kind during acute exacerbation 1, 2
- Avoid aggressive hydration in older children and adults (may be appropriate for infants/young children with dehydration) 3
- Do not routinely prescribe antibiotics unless strong evidence of bacterial infection (pneumonia, sinusitis) exists 3, 1
- Avoid methylxanthines, chest physiotherapy, and mucolytics 3
Disposition Criteria
Hospital Admission Indicated:
- Life-threatening features persist after initial treatment 1
- PEF remains <50% predicted after treatment 1
- Severe exacerbation features persist after 3 doses of bronchodilators 1
Discharge Criteria: